The Drinking Dashboard Study

June 7, 2023 updated by: Mary E Miller, University of Missouri-Columbia

Dynamic Personalized Feedback for Young Adults With a History of Blackout

This study aims to develop and pilot test the efficacy of a "Drinking Dashboard" providing participants weekly feedback on the risk factors and consequences of blackout.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Approximately 50% of young adults who drink alcohol experience alcohol-induced "blackouts," defined as permanent (en bloc) or temporary (fragmentary) memory loss for events that occurred while they are drinking. This experience of alcohol-induced blackout is associated prospectively with alcohol-related harm, including emergency room visits and sexual coercion, with medical care costs exceeding $469,000 per year. While young adults who have recently experienced a blackout report less favorable evaluations of drinking events and increased motivation to decrease their drinking, they do not actually change their drinking behavior as a result of the blackout alone. Collectively, these data suggest that blackouts may serve as an opportunity for intervention, after which young adults are more likely to respond to alcohol feedback. This R34 aims to develop an intervention tailored to individuals who experience blackouts. In the trial phase, 162 young adults (50% female, ≥50% non-college) who report a history of blackout will be randomly assigned to receive the intervention (n=81) or assessment only (n=81). Outcomes will be assessed immediately post-intervention and at 3-month follow-up.

Study Type

Interventional

Enrollment (Estimated)

162

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18-30 years of age
  • Binge drinking in a typical week
  • Any form of alcohol-induced memory impairment in the past month at baseline

Exclusion Criteria:

  • Psychiatric disorder requiring immediate clinical attention (e.g., psychosis, suicidal ideation with intent and plan)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Drinking Dashboard
Day-level feedback on alcohol use and consequences
Day-level feedback on alcohol use and consequences
No Intervention: Assessment Only
Daily assessment control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment
Time Frame: Baseline
% of screened participants who (yes/no) complete the baseline assessment (no specific tool)
Baseline
Retention
Time Frame: 3-month follow-up
% of randomized participants who (yes/no) complete 3-month follow-up assessment (no specific tool)
3-month follow-up
Acceptability
Time Frame: 1 month follow-up
Measured using the 8-item Client Satisfaction Questionnaire. Scored from 1 to 4, with higher scores indicating greater satisfaction with treatment.
1 month follow-up
Frequency of high-intensity drinking
Time Frame: Change from baseline to follow-up (1 and 3 months)
Measured using the Daily Drinking Questionnaire, which asks participants to indicate how many standard drinks they consumed on each day of a typical week in the past month.
Change from baseline to follow-up (1 and 3 months)
Peak BAC
Time Frame: Change from baseline to follow-up (1 and 3 months)
Measured using the Daily Drinking Questionnaire, which asks participants to indicate the maximum number of drinks consumed on one occasion in the past month.
Change from baseline to follow-up (1 and 3 months)
Frequency of blackouts
Time Frame: Change from baseline to follow-up (1 and 3 months)
Measured using the 8-item Alcohol-Induced Blackout Measure-2 (ABOM-2). Items are scored from 0 to 4, with higher scores indicating more frequent blackout experiences.
Change from baseline to follow-up (1 and 3 months)
Alcohol-related consequences
Time Frame: Change from baseline to follow-up (1 and 3 months)
Measured using the 24-item Brief Young Adult Alcohol Consequences Questionnaire (BYAACQ). Items scores yes/no, with higher scores indicating a greater number of consequences in the past month.
Change from baseline to follow-up (1 and 3 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sexual coercion
Time Frame: Difference in likelihood baseline vs 3 months
% of people indicating they (a) were coerced into sexual activity or (b) coerced someone else into sexual activity in the past 3 months
Difference in likelihood baseline vs 3 months
Emergency department visits
Time Frame: Difference in likelihood baseline vs 3 months
% of people indicating they visited the emergency department in the past 3 months
Difference in likelihood baseline vs 3 months
Blackout susceptibility
Time Frame: Change from baseline to follow-up (1 and 3 months)
How likely is it that you will lose memory of drinking events as a result of alcohol use in the next 30 days? Scored on a Likert scale, with higher scores indicating more susceptibility.
Change from baseline to follow-up (1 and 3 months)
Blackout severity
Time Frame: Change from baseline to follow-up (1 and 3 months)
If I were to have a blackout, bad things would happen. Scored on a Likert scale, with higher scores indicating more negative attitudes.
Change from baseline to follow-up (1 and 3 months)
Costs/benefits of drinking
Time Frame: Change from baseline to follow-up (1 and 3 months)
Measured using the Cunningham et al. (1997) scale of 16 benefits and 16 costs of decreasing alcohol use. Responses range 1 (not important) to 5 (extremely important).
Change from baseline to follow-up (1 and 3 months)
Blackout self-efficacy
Time Frame: Change from baseline to follow-up (1 and 3 months)
% confidence that participants could avoid a blackout, if they wanted to do so
Change from baseline to follow-up (1 and 3 months)
Sleep disturbance
Time Frame: Change from baseline to follow-up (1 and 3 months)
Measured using the Insomnia Severity Index. Items scored 0 to 4, with higher scores indicating more severe insomnia.
Change from baseline to follow-up (1 and 3 months)
Mood
Time Frame: Change from baseline to follow-up (1 and 3 months)
Measured using the Positive and Negative Affect Schedule. Scores range 1 (very slightly or not at all) to 5 (extremely), with higher scores indicating more positive/negative mood.
Change from baseline to follow-up (1 and 3 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mary Beth Miller, PhD, University of Missouri-Columbia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2023

Primary Completion (Estimated)

February 28, 2025

Study Completion (Estimated)

April 30, 2025

Study Registration Dates

First Submitted

November 7, 2022

First Submitted That Met QC Criteria

November 18, 2022

First Posted (Actual)

November 29, 2022

Study Record Updates

Last Update Posted (Actual)

June 9, 2023

Last Update Submitted That Met QC Criteria

June 7, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2067803

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified, individual-level data will be deposited online via the NIAAA Data Archive (NIAAADA). De-identified data, the survey protocol and instrument, and analysis code will also be made available to other qualified investigators upon request.

IPD Sharing Time Frame

Upon study completion

IPD Sharing Access Criteria

NOT-AA-19-020

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Drinking

Clinical Trials on Drinking Dashboard

3
Subscribe